Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. (Q51488073)

5 April 2018

title

Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. (English)

1 reference

5 April 2018

8

Marc Bessler

1 reference

5 April 2018

author name string

Judith Korner

1

1 reference

5 April 2018

William Inabnet

2

1 reference

5 April 2018

Irene M Conwell

3

1 reference

5 April 2018

Carmen Taveras

4

1 reference

5 April 2018

Amna Daud

5

1 reference

5 April 2018

Lorraine Olivero-Rivera

6

1 reference

5 April 2018

Nancy L Restuccia

7

1 reference

5 April 2018

publication date

1 September 2006

1 reference

5 April 2018

published in

Obesity

1 reference

5 April 2018

volume

14

1 reference

5 April 2018

page(s)

1553-1561

1 reference

5 April 2018

issue

9

1 reference

5 April 2018

Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Bariatric surgery: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Surgery for severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Bariatric surgery and long-term control of morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Long- or short-limb gastric bypass?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Gastrointestinal hormones and food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Structure and receptor binding of PYY analogs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Peptide YY: a key mediator of orexigenic behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Identification and characterization of the emetic effects of peptide YY

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

PYY3-36 as an anti-obesity drug target.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Gut hormone PYY(3-36) physiologically inhibits food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Inhibition of food intake in obese subjects by peptide YY3-36

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Effect of peptide YY3-36 on food intake in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Ghrelin induces adiposity in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Ghrelin causes hyperphagia and obesity in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

A role for ghrelin in the central regulation of feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Circulating ghrelin levels are decreased in human obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

The homeostasis model in the San Antonio Heart Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Ghrelin: a gut-brain hormone: effect of gastric bypass surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Vagotomy dissociates short- and long-term controls of circulating ghrelin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.179

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.179

1 reference

5 April 2018

PubMed ID

17030966

1 reference

5 April 2018